Sort
40,608 grants matching “prostate cancer”
Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer
$690,899David Vanderweele · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
$690,824David Basanta Gutierrez · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2017 · CA
A NEW LYSINE DEMETHYLASE AS A PROGRESSION FACTOR FOR PROSTATE CANCER
$690,814University Of California, Davis · · FY2010 · Department of the Army
Personalizing Post-Polypectomy Surveillance for Colorectal Cancer Prevention
$690,753Jeffrey Kuang Zou Lee · Kaiser Foundation Research Institute · R37 · FY2023 · CA
IDENTIFYING NOVEL SECRETED PROTEINS IN PROSTATE CANCER AS BIOMARKERS
$690,750Baylor College Of Medicine · · FY2010 · Department of the Army
Pathomic Predictors of Prostate Cancer Progression
$690,744Parag Kumar Mallick · Stanford University · R01 · FY2024 · CA
Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance
$690,647Qianben Wang · Duke University · R01 · FY2024 · CA
5mC and 5hmC DNA alterations as sensitive and specific biomarkers for the non-invasive early detection of pancreatic ductal adenocarcinoma
$690,637Ajay Goel · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA
Ionization Detail - Biologically based treatment planning for particle therapy beyond LET-RBE
$690,634Bruce Faddegon · University Of California, San Francisco · R01 · FY2022 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$690,581Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Diversity in the Cancer Care Workforce
$690,483Cary P Gross · Yale University · R01 · FY2024 · MD
Software to facilitate multimode, multiscale fused data for Pathology and Radiolo
$690,391Michael D Feldman · University Of Pennsylvania · R01 · FY2009 · CA
Prostate Cancer Immunotherapy
$690,294Rockefeller University · R01 · FY2005 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$690,195Georgetown University · N01 · FY2008 · CA
Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
$690,111Amit Singal · Ut Southwestern Medical Center · R01 · FY2017 · CA
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
$689,955Saul Priceman · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
$689,898Lawrence H Schwartz · Columbia University Health Sciences · R01 · FY2022 · CA
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
$689,887Beth Israel Deaconess Medical Center · U01 · FY2005 · CA
Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer
$689,827Joshua D Campbell · Boston University Medical Campus · R01 · FY2025 · CA
DEVELOPMENTAL FUNDS
$689,820Herbert Kim Lyerly · Duke University · P30 · FY2009 · CA
San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)
$689,813Ian M Thompson · University Of Texas Hlth Science Center · U01 · FY2011 · CA
Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer
$689,813Amir Goldkorn · University Of Southern California · R01 · FY2025 · CA
Phase II Clinical Trial of Polyphenon E in Prostate Cancer
$689,729Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Harvard/Michigan/Cornell Prostate Cancer Biomarker Clinical Validation Center
$689,700Martin G Sanda · Beth Israel Deaconess Medical Center · U01 · FY2012 · CA
Integrating Tobacco Treatment into Cancer Care
$689,597Elyse R Park · Massachusetts General Hospital · R01 · FY2015 · CA